| scholarly article | Q13442814 |
| P2093 | author name string | Chun-Hou Zheng | |
| Jin-Xing Liu | |||
| Xiang-Zhen Kong | |||
| Ying-Lian Gao | |||
| Dong-Qin Wang | |||
| P2860 | cites work | Selective growth inhibition in BRAF mutant thyroid cancer by the mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244. | Q40079043 |
| Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells | Q40109450 | ||
| Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3. | Q40498632 | ||
| Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines. | Q41817444 | ||
| The inhibition of ERK/MAPK not the activation of JNK/SAPK is primarily required to induce apoptosis in chronic myelogenous leukemic K562 cells | Q42487215 | ||
| Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism | Q43607424 | ||
| Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice | Q44622538 | ||
| A novel class of ethacrynic acid derivatives as promising drug-like potent generation of anticancer agents with established mechanism of action | Q46465852 | ||
| In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes | Q74223303 | ||
| Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43 | Q79400707 | ||
| Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cells | Q79794039 | ||
| Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11 | Q24338572 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 | Q24541450 | ||
| Gleevec inhibits β-amyloid production but not Notch cleavage | Q24683037 | ||
| Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth | Q24685474 | ||
| KEGG for integration and interpretation of large-scale molecular data sets | Q29547277 | ||
| Signalling pathways of the TNF superfamily: a double-edged sword | Q29616428 | ||
| CellMiner: a relational database and query tool for the NCI-60 cancer cell lines | Q33472990 | ||
| Drug target inference through pathway analysis of genomics data | Q34570294 | ||
| iFad: an integrative factor analysis model for drug-pathway association inference | Q36076329 | ||
| FacPad: Bayesian sparse factor modeling for the inference of pathways responsive to drug treatment | Q36307283 | ||
| Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information | Q36434850 | ||
| Congenital and acquired neutropenia consensus guidelines on diagnosis from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). | Q37859344 | ||
| Redox sensing and signaling by malaria parasite in vertebrate host | Q38367765 | ||
| Drug-target interaction prediction: databases, web servers and computational models | Q38568763 | ||
| The Pathway Analysis of Micrornas Regulated Drug-Resistant Responses in HeLa Cells | Q38719940 | ||
| ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib | Q39413108 | ||
| Efficient Drug-Pathway Association Analysis via Integrative Penalized Matrix Decomposition | Q39687586 | ||
| P433 | issue | 29 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 48075-48085 | |
| P577 | publication date | 2017-05-29 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Identifying drug-pathway association pairs based on L1L2,1-integrative penalized matrix decomposition | |
| P478 | volume | 8 |
| Q47202979 | Identifying drug-pathway association pairs based on L2,1-integrative penalized matrix decomposition | cites work | P2860 |
Search more.